Stay updated on Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study page now displays a 403 Forbidden error screen, replacing the normal study details with a generic error message; this indicates access is blocked rather than an update to the trial information.SummaryDifference20%

- Check36 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a minor administrative update to the page metadata. This change reflects an updated revision tag rather than modifications to the study content or user-facing information.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor site release. The change reflects an internal update to the page's underlying code or assets rather than a change to study content.SummaryDifference0.0%

- Check57 days agoChange DetectedA new entry '2023 ( U.S. NIH Grant/Contract )' was added under Other Study ID Numbers, indicating NIH funding for the study. This funding attribution clarifies the study's government support but does not change its design, eligibility, or reported outcomes.SummaryDifference0.0%

Stay in the know with updates to Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.